Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 20172016)

Published in Exp Hematol on February 19, 2010

Authors

Véronique Decot1, Laure Voillard, Véronique Latger-Cannard, Lamia Aissi-Rothé, Pascale Perrier, Jean Francois Stoltz, Daniele Bensoussan

Author Affiliations

1: Unité de Thérapie Cellulaire et Tissus, CHU Nancy, Nancy, France. v.decot@chu-nancy.fr

Articles citing this

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One (2012) 2.09

The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells. Blood (2010) 1.60

Natural killer cells in human cancer: from biological functions to clinical applications. J Biomed Biotechnol (2011) 1.28

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications. Cytotherapy (2012) 1.27

Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J Cell Biol (2011) 1.26

Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century. Stem Cells Int (2015) 1.12

Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1. Blood (2011) 1.04

T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect. Haematologica (2015) 1.02

Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report. J Clin Oncol (2010) 0.99

Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation. Blood (2014) 0.85

Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors. Mediators Inflamm (2013) 0.85

PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells. Oncotarget (2016) 0.84

Interleukin-7 and interleukin-15 for cancer. J Cancer (2014) 0.78

"Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy. Biomed Res Int (2015) 0.77

A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma. Clin Dev Immunol (2013) 0.77

Immunomodulation of endothelial differentiated mesenchymal stromal cells: impact on T and NK cells. Immunol Cell Biol (2015) 0.77

Articles by these authors

WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood (2004) 2.41

Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis. Haematologica (2004) 1.82

HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant (2007) 1.77

C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Thromb Haemost (2008) 1.53

Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions. Eur J Hum Genet (2008) 1.14

Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis. Haematologica (2012) 1.13

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2009) 1.12

Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat (2014) 0.97

C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway. Atherosclerosis (2008) 0.94

Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells. Transfusion (2003) 0.87

Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo. Am J Physiol Endocrinol Metab (2002) 0.86

Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression. Mol Cell Endocrinol (2005) 0.86

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation. Transpl Immunol (2011) 0.85

T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. Br J Haematol (2002) 0.83

Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome: an eight-year follow-up. Clin Immunol (2008) 0.82

Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context. Curr Stem Cell Res Ther (2014) 0.80

Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant. Transpl Immunol (2009) 0.79

Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort. Hum Mutat (2015) 0.79

Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment. J Leukoc Biol (2007) 0.77

Autologous cell based therapy for treating chronic infarct myocardium. Clin Hemorheol Microcirc (2005) 0.77

[Biclonal or biphenotypic chronic lymphotic leukemia? An answer brought by the treatment]. Ann Biol Clin (Paris) (2011) 0.77

Crucial microscopic features leading to diagnosis of cobalamin C deficiency in a new-born. Br J Haematol (2013) 0.75

Hemoglobin-based oxygen carriers do not alter platelet functions: study of three chemically modified hemoglobin solutions. Intensive Care Med (2002) 0.75

New mutation in the beta 3-integrin (GPIIIa) gene inducing HPA-1 genotyping discrepancies. Transfusion (2010) 0.75

Identification of an acute basophilic leukaemia carrying a rare e6a2 BCR-ABL transcript. Acta Haematol (2006) 0.75

Platelet counting. Methods Mol Biol (2013) 0.75

Fatal peri-operative hyperacute graft rejection during heart transplantation related to infusion of red blood cell concentrate. J Heart Lung Transplant (2012) 0.75

CD203c /CD117-, an useful phenotype profile for acute basophilic leukaemia diagnosis in cases of undifferentiated blasts. Leuk Lymphoma (2007) 0.75

Immunoadsorption of alloantibodies onto erythroid membrane antigens encapsulated into polymeric microparticles. Pharm Res (2007) 0.75

Thawed autologous peripheral blood stem cells require modified quantification methods for hematopoietic progenitor cell evaluation. Biomed Mater Eng (2012) 0.75